Article

Building on the clinical applicability of ctDNA analysis in non-metastatic pancreatic ductal adenocarcinoma

2024-05-02

Abstract excerpt

<title>Abstract</title> <p><bold>Background.</bold> Pancreatic ductal adenocarcinoma (PDAC) represents one of the worst prognostic cancers worldwide, with a high recurrence rate after adjuvant or neoadjuvant therapy (NAT). Circulating tumor DNA (ctDNA) analysis raised as a promising non-invasive tool to characterize tumor genomics and to assess treatment response.<bold>Methods.</bold> In this study, surgical tumo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 286e0942-6388-5149-ae51-dd642d4e3744
DOI: 10.21203/rs.3.rs-4293455/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Building on the clinical applicability of ctDNA analysis in non-metastatic pancreatic ductal adenocarcinomaDOI 10.21203/rs.3.rs-4293455/v1Read

Building on the clinical applicability of ctDNA analysis in non-metastatic pancreatic ductal adenocarcinoma.Semantic proximity Read

Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenocarcinoma.Semantic proximity Read

Circulating tumor DNA: toward evolving the clinical paradigm of pancreatic ductal adenocarcinomaSemantic proximity Read

Cell free DNA in patients with pancreatic adenocarcinoma: clinicopathologic correlationsSemantic proximity Read

Clinical correlates of blood-derived circulating tumor DNA in pancreatic cancer.Semantic proximity Read

Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer.Semantic proximity Read

Molecular classification as prognostic factor and guide for treatment decision of pancreatic cancer.Semantic proximity Read

Evaluation of circulating tumor DNA as a biomarker in pancreatic cancer with liver metastasisSemantic proximity Read

Cell free DNA in patients with pancreatic adenocarcinoma: clinicopathologic correlations.Semantic proximity Read

Improved Assessment of Response Status in Patients with Pancreatic Cancer Treated with Neoadjuvant Therapy using Somatic Mutations and Liquid Biopsy Analysis.Semantic proximity Read

ctDNA whole exome sequencing in pancreatic ductal adenocarcinoma unveils organ-dependent metastatic mechanisms and identifies actionable alterations in fast progressing patients.Semantic proximity Read

Molecular Profiling and Survival Outcomes in Pancreatic Ductal Adenocarcinoma: A Multicenter Real-World Study from Turkey.Semantic proximity Read